Literature DB >> 10616087

Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia.

P W Huh1, L Belayev, W Zhao, S Koch, R Busto, M D Ginsberg.   

Abstract

OBJECT: The purpose of this study was to compare the effects of prolonged hypothermia on ischemic injury in a highly reproducible model of middle cerebral artery (MCA) occlusion in rats.
METHODS: Male Sprague-Dawley rats were anesthetized with halothane and subjected to 120 minutes of temporary MCA occlusion by retrograde insertion of an intraluminal nylon suture coated with poly-L-lysine through the external carotid artery into the internal carotid artery and the MCA. Two levels of prolonged postischemic cranial hypothermia (32 degrees C and 27 degrees C) and one level of intraischemic cranial hypothermia (32 degrees C) were compared with the ischemic normothermia (37 degrees C) condition. Target cranial temperatures were maintained for 3 hours and then gradually restored to 35 degrees C over an additional 2-hour period. The animals were evaluated using a quantitative neurobehavioral battery of tests before inducing MCA occlusion, during occlusion (at 60 minutes postonset in all rats except those in the intraischemic hypothermia group), and at 24, 48, and 72 hours after reperfusion. The rat brains were perfusion fixed at 72 hours after ischemia, and infarct volumes and brain edema were determined. Both intraischemic and postischemic cooling to 32 degrees C led to similar significant reductions in cortical infarct volume (by 89% and 88%, respectively) and total infarct volume (by 54% and 69%, respectively), whereas postischemic cooling to 27 degrees C produced lesser reductions (64% and 49%, respectively), which were not statistically significant. All three hypothermic regimens significantly lessened hemispheric swelling and improved the neurological score at 24 hours. The authors' data confirm that a high degree of histological neuroprotection is conferred by postischemic cooling to 32 degrees C, which is virtually equivalent to that observed with intraischemic cooling to the same level.
CONCLUSIONS: These results may be relevant to the design of future clinical trials of therapeutic hypothermia for acute ischemic stroke.

Entities:  

Mesh:

Year:  2000        PMID: 10616087     DOI: 10.3171/jns.2000.92.1.0091

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  29 in total

1.  Therapeutic applications of hypothermia in cerebral ischaemia.

Authors:  Bruno P Meloni; Frank L Mastaglia; Neville W Knuckey
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

Review 2.  Neuroprotection for ischemic stroke using hypothermia.

Authors:  Angelos-Aristeidis Konstas; Jae H Choi; John Pile-Spellman
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

4.  LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.

Authors:  Ludmila Belayev; Larissa Khoutorova; Kristal Atkins; William C Gordon; Julio Alvarez-Builla; Nicolas G Bazan
Journal:  Exp Neurol       Date:  2008-08-28       Impact factor: 5.330

Review 5.  Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.

Authors:  Marcus R Chacon; Matt B Jensen; Justin A Sattin; Justin A Zivin
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

6.  Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation.

Authors:  Dean A Le; Yongqin Wu; Zhihong Huang; Kohji Matsushita; Nikolaus Plesnila; Jean C Augustinack; Bradley T Hyman; Junying Yuan; Keisuke Kuida; Richard A Flavell; Michael A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

7.  Excess of homozygosity in the major histocompatibility complex in schizophrenia.

Authors:  Semanti Mukherjee; Saurav Guha; Masashi Ikeda; Nakao Iwata; Anil K Malhotra; Itsik Pe'er; Ariel Darvasi; Todd Lencz
Journal:  Hum Mol Genet       Date:  2014-06-18       Impact factor: 6.150

Review 8.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 9.  Hypothermia as a cytoprotective strategy in ischemic tissue injury.

Authors:  Xian N Tang; Midori A Yenari
Journal:  Ageing Res Rev       Date:  2009-10-13       Impact factor: 10.895

Review 10.  Combination therapy with hypothermia for treatment of cerebral ischemia.

Authors:  Xian N Tang; Liping Liu; Midori A Yenari
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.